Essilor Stellest® is the first and only FDA market authorized⁣ spectacle lens to slow #myopia progression in children*¹ in the⁣ United States. Available at LensCrafters. #Essilor⁣ #Stellest #LensCrafters ​⁣ ⁣ *Compared to single vision lenses. Results from a prospective,⁣ randomized, double-masked, multicenter U.S. clinical trial in myopic⁣ children aged 6–12 years at initiation of treatment.​⁣ ⁣ ¹ Essilor International, data on file (2025)